Major events:

Genscript Bio (01548): The new drug application for cilta-cel has been approved.

China Circ (01763) completed the first domestic introduction and landing of the emerging therapeutic nuclide terbium-161.

Haier SmartHome (06690) plans to invest in the construction of a new project with an annual output of 5 million air conditioners.

Anta Sports (02020) plans to use no more than 10 billion Hong Kong dollars to repurchase shares.

JD Group-SW (09618) announces a new share repurchase plan of $5 billion.

Business performance:

Ctrip Group-S (09961) second quarter net profit attributable to shareholders was 3.833 billion yuan, a significant increase of 507.45% year-on-year. Strong growth in the tourism business.

Anta Sports (02020) released its interim performance, achieving revenue of 337.35 million yuan, a year-on-year increase of 13.8%, further consolidating its leading position in the Chinese sports brand.

China Resources Power (00836) announced its interim results, with a net profit attributable to shareholders of HKD 9.363 billion, a year-on-year increase of 38.9%. The interim dividend per share is HKD 0.455.

Conch Cement (00914) released its interim performance with a net income of 3.326 billion yuan, a decrease of 48.56% year-on-year.

Haidilao (06862) announced its interim results with a net profit attributable to owners of approximately 2.038 billion yuan, a year-on-year decrease of 9.74%.

Fosun Pharma (02196) achieved a revenue of approximately 20.463 billion yuan in the first half of the year, with a net profit attributable to the parent company of approximately 1.225 billion yuan. The revenue from innovative drugs has maintained steady growth.

China Taiping (00966) reported a year-on-year increase of 15.4% in net profit attributable to shareholders to HKD 6.027 billion in 2024. Taiping Life's NBV increased by 83.6% year-on-year.

Chinacomservice (00552) announced its interim results, with a net income attributable to shareholders of 2.125 billion yuan, a year-on-year increase of 4.4%.

Za online (06060) announced its interim performance, achieving insurance service revenue of 15.088 billion yuan, a year-on-year growth of 19.0%.

sjm holdings (00880) announced its interim results, with a shareholder's net loss of 0.162 billion HKD, a year-on-year narrowing of 87.18%.

China OVS PPT (02669) announces interim results, with shareholders' attributable net profit of 0.738 billion yuan, an increase of 15.97% year-on-year.

Datang Renew (01798) announced its interim performance. The net profit attributable to the parent company is approximately 1.765 billion yuan, a decrease of 15.67% year-on-year.

yihai intl (01579) released its interim performance, with a net profit attributable to shareholders of 0.308 billion yuan, a decrease of 13.85% year-on-year.

Guotai Junan International (01788) released its interim performance, maintaining its industry-leading position in bond underwriting. The shareholders' share of attributable surplus increased by 0.195 billion Hong Kong dollars, a year-on-year increase of 63.24%.

Amara Biology (06955) released its interim results, with a net profit attributable to shareholders of 61.672 million yuan, turning losses into gains compared to the same period last year.

chow sang sang (00116) announced its interim results, with a shareholder's share of profit of 0.526 billion Hong Kong dollars, a 36% year-on-year decrease. Interim dividend of 15 Hong Kong cents per share.

Nai Xue Tea (02150) achieved revenue of approximately 2.544 billion yuan in the first half of the year, with a net addition of 23 Nai Xue Tea directly operated stores.

For more details, please refer to the CITIC Securities website ().